Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00457756 · ClinicalTrials.gov registry record · NA

The Effect of BiosLife on Serum Lipids

A NA study of Hypercholesterolemia, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT00457756 is a NA study of Hypercholesterolemia that has completed, run by University of Utah. The registered enrollment target is 100 participants, below the 815-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00457756, a NA study of Hypercholesterolemia, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This is a double-blind, placebo-controlled study to assess the effectiveness of BiosLife in lowering serum LDL cholesterol and raising HDL cholesterol. BiosLife is a natural supplement (mixed in water and taken twice daily) which contains guar gum and other natural soluble fibers, phytosterols, policosanol, and a proprietary chrysanthemum extract. Approximately 100 subjects with baseline LDL cholesterol of 110-190 mg/dL will be randomized in a 2:1 ratio to BiosLife or a look-alike placebo. Changes in lipids from baseline will be assessed at 6 weeks and 12 weeks.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT BiosLife Complete

Study Locations (1)

Utah

  • Cardiovascular Genetics, University of Utah, 420 Chipeta Way, Room 1160 - Salt Lake City

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2007-01
Est. Completion 2007-07
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT00457756

The ClinicalTrials.gov registry entry for NCT00457756 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 815-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (88% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypercholesterolemia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00457756 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT00457756 about?

NCT00457756 is a clinical study titled "The Effect of BiosLife on Serum Lipids". This is a double-blind, placebo-controlled study to assess the effectiveness of BiosLife in lowering serum LDL cholesterol and raising HDL cholesterol. BiosLife is a natural supplement (mixed in water and taken twice daily) which contains guar gum and other natural soluble fibers, phytosterols, poli...

What is the current status of trial NCT00457756?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2007-01. Estimated completion is 2007-07.

What conditions does trial NCT00457756 study?

This clinical trial studies the following conditions: Hypercholesterolemia.

What interventions are being tested in trial NCT00457756?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), BiosLife Complete (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00457756?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00457756 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypercholesterolemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.